Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014
Clinicopathologic Conference, Susacs Syndrome (retinocochleocerebral vasculopathy)
NEJM 365:549-559, Case 24-2011, 2011
Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
Medicine 82:216-223, Rojas-Marcos,I.,et al, 2003
Central Nervous System Manifestations of Periarteritis Nodosa
Neurol 15:114, Ford,R.G.,et al, 1965
Clinicopathologic Conference, Susacs Syndrome
NEJM 379:2152-2159, Case 37-2018, 2018
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Turning a Blind Eye
Lancet 349:1740, Bapat,V.N.&Tendolkar,A.G., 1997
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Facioscapulohumeral Dystrophy, In Skeletal Muscle Pathology
Churchhill Livingstone, NY, p285, 30392., Mastaglia,F.L.&Walton,J., 1992
A Clinical Triad to Diagnose Paraneoplastic Retinopathy
Ann Neurol 28:162-167, Jacobson,D.M.,et al, 1990
Mitochondrial Myopathies:Clinical & Biochem Features of 30 Patients with Major Deletions of Muscle Mitochondrial DNA
Ann Neurol 26:699-708, Hold,I.J.,et al, 1989
Retinitis Pigmentosa
Surv Ophthalmol 33:137-177, Pagon,R.A., 1988
Neurological Complications of Acquired Immune Deficiency Syndrome:Analysis of 50 Patients
Ann Neurol 14:403-418, Snider,W.D.,et al, 1983
Genetic Counseling in Retinitis Pigmentosa
MCV Quart 8:283, Noah,V., 1972